Literature DB >> 21655999

[Neuroendocrine neoplasms of the appendix and colorectum].

G Klöppel1, H Scherübl.   

Abstract

Appropriate diagnosis and treatment of neuroendocrine neoplasms (NENs) of the appendix and colorectum requires a detailed knowledge of their proper classification according to the updated WHO and TNM systems. The WHO classification distinguishes well differentiated NEN, the neuroendocrine tumors (G1 and G2 NETs), from the poorly differentiated carcinomas (G3 NECs). While NETs are common in the appendix and rectum, NECs occur predominantly in the colon. G1 appendiceal and rectal NETs of 1 cm in size or below that do not invade either the muscular wall or vessels bear almost no metastatic risk and can be treated by appendectomy or endoscopic resection. G2 appendiceal and rectal NETs larger than 1 cm in size in combination with other risk factors have an increased risk of metastasis and need to be treated more aggressively. NECs of the colon usually require chemotherapy in addition to resection. Today, most patients with NETs of the appendix and rectum have an excellent prognosis when these diagnostic and therapeutic guidelines are borne in mind.

Entities:  

Mesh:

Year:  2011        PMID: 21655999     DOI: 10.1007/s00292-011-1438-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  25 in total

1.  Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma.

Authors:  Ursula Plöckinger; Anne Couvelard; Massimo Falconi; Anders Sundin; Ramon Salazar; Emanuel Christ; Wouter W de Herder; David Gross; Wolfram H Knapp; Ulrich P Knigge; Matthew H Kulke; Ulrich F Pape
Journal:  Neuroendocrinology       Date:  2007-10-11       Impact factor: 4.914

Review 2.  Rectal carcinoids are on the rise: early detection by screening endoscopy.

Authors:  H Scherübl
Journal:  Endoscopy       Date:  2009-02-12       Impact factor: 10.093

3.  CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.

Authors:  Stefano La Rosa; Elena Rigoli; Silvia Uccella; Anna Maria Chiaravalli; Carlo Capella
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

4.  Carcinoid tumours of the appendix in children 1957-1986: incidence, treatment and outcome.

Authors:  S E Parkes; K R Muir; M al Sheyyab; A H Cameron; J R Pincott; F Raafat; J R Mann
Journal:  Br J Surg       Date:  1993-04       Impact factor: 6.939

5.  Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor.

Authors:  Giulio Rossi; Federica Bertolini; Giuliana Sartori; Nazzarena Bigiani; Alberto Cavazza; Moira Foroni; Riccardo Valli; Guido Rindi; Carmela De Gaetani; Gabriele Luppi
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

Review 6.  [Rectal carcinoids on the rise - update].

Authors:  H Scherübl; G Klöppel
Journal:  Z Gastroenterol       Date:  2009-04-08       Impact factor: 2.000

7.  Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.

Authors:  Laura H Tang; Jinru Shia; Robert A Soslow; Deepti Dhall; W Douglas Wong; Eileen O'Reilly; Jing Qin; Philip Paty; Martin R Weiser; Jose Guillem; Larissa Temple; Leslie H Sobin; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2008-10       Impact factor: 6.394

Review 8.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

9.  Carcinoid tumors of the appendix. Mesoappendiceal extension and nodal metastases.

Authors:  D C Syracuse; K H Perzin; J B Price; P D Wiedel; R Mesa-Tejada
Journal:  Ann Surg       Date:  1979-07       Impact factor: 12.969

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  4 in total

Review 1.  [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 2.  [Rectal neuroendocrine tumors: endoscopic therapy].

Authors:  J Eick; J Steinberg; C Schwertner; W Ring; H Scherübl
Journal:  Chirurg       Date:  2016-04       Impact factor: 0.955

3.  Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany.

Authors:  Hans Scherübl; Brigitte Streller; Roland Stabenow; Hermann Herbst; Michael Höpfner; Christoph Schwertner; Joachim Steinberg; Jan Eick; Wanda Ring; Krishna Tiwari; Sören M Zappe
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

4.  Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems.

Authors:  Chaoyong Shen; Yuan Yin; Huijiao Chen; Sumin Tang; Xiaonan Yin; Zongguang Zhou; Bo Zhang; Zhixin Chen
Journal:  Oncotarget       Date:  2017-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.